We also studied an association between the above polymorphisms of the UBC9 gene and clinical characteristics of breast cancer patients such as tumor grade, tumor stage and ER and PR (estrogen and progesterone receptors, respectively) and HER2 expression (human epidermal growth factor 2). This evidence concerns the gene ESR1 and neoplasm.